This patent teaches how to use hematopoietic stem cells as a stem cell source for the generation of dendritic cells. Since the dendritic cell is the most potent stimulator of the immune system, this patent is useful for generating a biological adjuvant for vaccines. The patent teaches that activation of the rel gene through a unique construct can be used for generation of dendritic cells out of hematopoietic stem cells.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.